To Be Free and Normal: Addiction, Governance, and the Therapeutics of Buprenorphine. (18th August 2015)

• Record Type: Journal Article
• Authors: Harris, Shana
• Is Part Of: Medical anthropology quarterly. Volume 29:Number 4(2015:Dec.)
• Page Start: 512
• Page End: 530
• Publication Date: 2015-08-18
• Subjects: buprenorphine -- drug treatment -- freedom -- normalcy -- governance; Medical anthropology -- Periodicals; Anthropology -- Periodicals; Antropología médica -- Publicaciones periódicas; Anthropologie médicale -- Périodiques; Médecine sociale -- Périodiques; Ethnomédecine -- Périodiques; Medische antropologie; Anthropologie médicale; Computer network resources; Périodique électronique (Descripteur de forme); Ressource Internet (Descripteur de forme); 306.461
• DOI: 10.1111/maq.12232
• Languages: English
• ISSNs: 0745-5194

Abstract

Abstract : Methadone maintenance has dominated opiate addiction treatment in the United States for decades. Since 2002, opiate addiction has also been treated in general medical settings with a substance called buprenorphine. Based on interviews and participant observation conducted in northern California, this article analyzes how discourses of freedom and normalcy in patient and provider narratives reflect and affect experiences with this treatment modality. I discuss how buprenorphine treatment, in contrast to methadone maintenance, offers patients and providers a greater sense of autonomy and flexibility in how they receive and deliver treatment. It presents them with new obligations, responsibilities, and choices around care and conduct. It simultaneously perpetuates and shapes a desire to be "free" and "normal." I argue that the therapeutics of buprenorphine govern patients and providers through this desire for freedom and normalcy. Buprenorphine is thus a technology of governmentality that extends neoliberal discourses and values and produces self‐governing subjects.